• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性髓系白血病不同演变阶段外周血中性粒细胞髓系分化抗原的研究

A study of the myeloid differentiation antigens of the peripheral blood neutrophil granulocytes in the different evolutive phases of chronic myeloid leukemia.

作者信息

Rozman M, Cervantes F, Rozman C

机构信息

Postgraduate School of Hematology, Farreras Valentí, Hospital Clinic, University of Barcelona, Spain.

出版信息

Ann Hematol. 1991 Jun;62(6):221-4. doi: 10.1007/BF01729836.

DOI:10.1007/BF01729836
PMID:1854885
Abstract

To ascertain whether progression from the chronic to the accelerated and blastic phases of chronic myeloid leukemia (CML) is associated with the loss of the myeloid differentiation antigens of the neutrophil granulocytes (NG), we analyzed two monoclonal antibodies (PMN 31D8 and PMN 13F6) recognizing normal peripheral blood NG membrane antigens in 49 patients in different evolutive stages of CML. Since five patients were studied twice, a total of 54 studies were carried out. Fourteen patients were evaluated at diagnosis, 12 in the controlled chronic phase within 1 year from diagnosis, 14 in the advanced chronic phase (median evolution 3.25 years), and 14 in the accelerated (five cases) or blastic (nine cases) phases. Fourteen normal subjects served as a control group. At diagnosis, a significant decrease in the positivity for both antigens was observed with respect to controls, probably due to the circulation of incompletely mature NG. In the early chronic phase the values were within the normal range, whereas a significant decrease was registered in the advanced chronic phase and especially in the accelerated/blastic phase. A negative correlation between the NG positivity for both markers and the time elapsed from the moment of obtaining the initial control of the disease was found, suggesting that a progressive loss of the myeloid antigens of the NG occurs during the evolutive course of CML. These results seem to confirm the usefulness of the NG myeloid differentiation antigen study as an evolutive parameter in CML.

摘要

为了确定慢性髓系白血病(CML)从慢性期进展到加速期和急变期是否与中性粒细胞(NG)髓系分化抗原的丧失有关,我们分析了两种识别正常外周血NG膜抗原的单克隆抗体(PMN 31D8和PMN 13F6),研究对象为49例处于CML不同演变阶段的患者。由于5例患者进行了两次研究,因此共进行了54次研究。14例患者在诊断时接受评估,12例在诊断后1年内处于慢性稳定期,14例处于慢性进展期(中位病程3.25年),14例处于加速期(5例)或急变期(9例)。14名正常受试者作为对照组。诊断时,观察到两种抗原的阳性率相对于对照组显著降低,这可能是由于未完全成熟的NG循环所致。在慢性早期,各项值在正常范围内,而在慢性进展期,尤其是在加速期/急变期,出现了显著下降。发现两种标志物的NG阳性率与疾病首次获得控制后经过的时间呈负相关,这表明在CML的演变过程中,NG的髓系抗原逐渐丧失。这些结果似乎证实了NG髓系分化抗原研究作为CML演变参数的有用性。

相似文献

1
A study of the myeloid differentiation antigens of the peripheral blood neutrophil granulocytes in the different evolutive phases of chronic myeloid leukemia.慢性髓系白血病不同演变阶段外周血中性粒细胞髓系分化抗原的研究
Ann Hematol. 1991 Jun;62(6):221-4. doi: 10.1007/BF01729836.
2
Sequential study of myeloid differentiation antigens of neutrophil granulocytes in different phases of chronic myeloid leukaemia: natural history and prognostic significance.慢性髓性白血病不同阶段中性粒细胞髓系分化抗原的序贯研究:自然病程及预后意义
Leukemia. 1993 Jan;7(1):80-5.
3
Abnormal expression of N-CAM (CD56) adhesion molecule on myeloid and progenitor cells from chronic myeloid leukemia.慢性髓性白血病髓系细胞和祖细胞上N-CAM(CD56)黏附分子的异常表达
Leukemia. 1993 Oct;7(10):1570-5.
4
A neutrophil membrane marker reveals two groups of chronic myelogenous leukemia and its absence may be a marker of disease progression.
Blood. 1986 Aug;68(2):343-6.
5
Chronic myeloid leukemia: correlation between purine metabolism enzyme activities and membrane immunophenotype.慢性粒细胞白血病:嘌呤代谢酶活性与膜免疫表型之间的相关性
Neoplasma. 1995;42(1):9-14.
6
Expression of hematopoietic progenitor cell associated antigen CD34 in chronic myeloid leukemia.造血祖细胞相关抗原CD34在慢性髓性白血病中的表达
Leuk Res. 1991;15(7):603-8. doi: 10.1016/0145-2126(91)90029-s.
7
[Decrease of CD16 antigen density on granulocytes in chronic myeloid leukemia].[慢性髓性白血病中粒细胞上CD16抗原密度的降低]
Rinsho Byori. 1992 Sep;40(9):997-8.
8
Surface expression of CD11b/CD18 of pseudo-Pelger granulocytes in chronic myeloid leukaemia.慢性髓系白血病中假性Pelger粒细胞CD11b/CD18的表面表达
Br J Haematol. 1990 Oct;76(2):215-20. doi: 10.1111/j.1365-2141.1990.tb07874.x.
9
Monoclonal antibodies against human granulocytes and myeloid differentiation antigens.抗人粒细胞和髓系分化抗原的单克隆抗体。
Hum Immunol. 1982 Dec;5(4):309-23. doi: 10.1016/0198-8859(82)90022-2.
10
Heterogeneity in the expression of Fc gammaRIII in morphologically mature granulocytes from patients with chronic myeloid leukemia.慢性髓性白血病患者形态学成熟粒细胞中FcγRIII表达的异质性。
Leuk Res. 1997 Mar;21(3):225-34. doi: 10.1016/s0145-2126(96)00118-x.

本文引用的文献

1
Functional and biochemical phenotype in relation to cellular age of differentiated neutrophils in chronic myeloid leukaemia.
Br J Haematol. 1982 Jul;51(3):339-44. doi: 10.1111/j.1365-2141.1982.tb02789.x.
2
Chronic myelogenous leukemia--new concepts (first of two parts).慢性粒细胞白血病——新概念(两部分中的第一部分)
N Engl J Med. 1981 May 14;304(20):1201-9. doi: 10.1056/NEJM198105143042004.
3
A multivariate analysis of prognostic factors in chronic myeloid leukemia.慢性髓性白血病预后因素的多变量分析。
Blood. 1982 Dec;60(6):1298-304.
4
Relationship of the duration of the chronic phase in chronic granulocytic leukaemia to the need for treatment during the first year after diagnosis.
Cancer Chemother Pharmacol. 1982;8(2):205-10. doi: 10.1007/BF00255485.
5
Staging of chronic myeloid leukaemia.慢性髓性白血病的分期
Br J Haematol. 1981 Jan;47(1):105-19. doi: 10.1111/j.1365-2141.1981.tb02765.x.
6
Prognostic discrimination in "good-risk" chronic granulocytic leukemia.“低危”慢性粒细胞白血病的预后判别
Blood. 1984 Apr;63(4):789-99.
7
Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).使用碱性磷酸酶与单克隆抗碱性磷酸酶的免疫复合物(碱性磷酸酶抗碱性磷酸酶复合物,APAAP复合物)对单克隆抗体进行免疫酶标记。
J Histochem Cytochem. 1984 Feb;32(2):219-29. doi: 10.1177/32.2.6198355.
8
Clinical implications of cytogenetic variants in chronic myelocytic leukemia (CML).慢性粒细胞白血病(CML)细胞遗传学变异的临床意义
Blood. 1968 Nov;32(5):755-66.
9
Marrow transplantation for the treatment of chronic myelogenous leukemia.骨髓移植治疗慢性粒细胞白血病。
Ann Intern Med. 1986 Feb;104(2):155-63. doi: 10.7326/0003-4819-104-2-155.
10
A neutrophil membrane marker reveals two groups of chronic myelogenous leukemia and its absence may be a marker of disease progression.
Blood. 1986 Aug;68(2):343-6.